Please use this identifier to cite or link to this item:
|Title:||Monoclonal antibodies against a phencyclidine derivative are used to investigate protein-ligand interactions|
|Authors:||Stefano O. Casalotti|
Alan P. Kozikowski
Karl E. Krueger
Mayo Clinic in Jacksonville, Florida
Georgetown University School of Medicine
|Keywords:||Pharmacology, Toxicology and Pharmaceutics|
|Citation:||European Journal of Pharmacology: Molecular Pharmacology. Vol.247, No.2 (1993), 209-213|
|Abstract:||Monoclonal antibodies against the irreversible alkylator N-ethyl-1-[2-(4-isothiocyanothienyl)]cyclohexylamine (ITCE) of the 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) binding site of the N-methyl-d-aspartate receptor were raised. Each antibody was characterized in a competition enzyme-linked immunosorbent assay (ELISA) with a range of TCP analogs. It was found that each monoclonal antibody has a different affinity profile for the various TCP analogs. No correlation between the structure of the side chain groups of each compound and the selective affinities of the antibodies could be deduced, indicating that the overall affinity of the antibodies is determined by more than just the sum of the interaction forces with each ligand's functional groups. In addition to the possible identification of endogenous TCP-like compounds these antibodies could be used as a model to study the molecular interaction between drugs and their receptors' active sites. © 1993.|
|Appears in Collections:||Scopus 1991-2000|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.